What is the recommendation regarding the administration of high-dose albumin for the treatment of patients with AIS?
The administration of high-dose albumin is not recommended for the treatment of patients with AIS. This recommendation was revised from the 2013 AIS Guidelines. This is based on the combined analysis of the ALIAS parts I and II trials which demonstrated no difference between the groups in 90-day disability.